Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport SHP2 inhibition combined with MEK, ERK, and KRAS G12C inhibitors is redefining treatment strategy for KRAS-driven PDAC, NSCLC, and colorectal cancer. Full pipeline analysis.
Article | Rapport Explore the 2026 magnetic microneedle technology landscape: patent trends, key assignees, magnetic actuation clusters, and strategic IP white spaces across 80+ records.
Article | Rapport A 2026 technology landscape of quantum dot infrared photodetectors (QDIPs): material systems, patent clusters, geographic activity, and emerging directions for R&D and IP strategy.
Article | Rapport How EUV photon shot noise, acid diffusion blur, and polymer microstructure drive LER at 3nm gate pitch — and the materials, process, and etch strategies that reduce transistor variability.
Article | Rapport SHP2 inhibition combined with KRAS G12C, MEK, and ERK inhibitors is reshaping treatment strategies for PDAC, NSCLC, and colorectal cancer. Explore the evidence.
Article | Rapport How photoresist LER drives transistor variability at 3nm gate pitch — root causes, device impact, and proven mitigation strategies from 20+ patents and papers.
Article | Rapport Explore the 2026 QDIP technology landscape: material systems, patent clusters, geographic trends, and emerging directions in infrared photodetector innovation.
Article | Rapport How substrate noise coupling degrades RF performance in bulk CMOS versus SOI technology for 5G transceivers — mechanisms, data, and patented mitigation strategies.
Article | Rapport How STING agonists, RIG-I activators, ENPP1 inhibitors, and advanced delivery platforms are reprogramming the tumor microenvironment in solid tumors.
Article | Rapport Enzymes, engineered microbes, and hybrid electro-biological systems are rewriting the carbon capture playbook. Explore the 2026 biocatalytic CO₂ technology landscape.
Article | Rapport How substrate noise coupling degrades RF performance in bulk CMOS versus SOI technology for 5G transceivers—mechanisms, circuit impacts, and patented mitigation strategies.
Article | Rapport Enzymes, engineered microbes, and hybrid electro-biological systems are reshaping CO₂ capture. Explore the 2026 biocatalytic carbon capture technology landscape.
Article | Rapport Explore the NK cell therapy pipeline across hematologic and solid tumors — CAR-NK, iPSC-derived, CIML, and NK engager strategies shaping immuno-oncology in 2025.
Article | Rapport How directed self-assembly (DSA) complements EUV lithography for sub-30 nm contact hole patterning at 3–5 nm nodes. Key materials, process strategies, and IP landscape.
Article | Rapport How CAR-NK, allogeneic, and iPSC-derived NK cell therapies are reshaping immuno-oncology — covering AML, solid tumors, and the evolving target landscape.